Prime Medicine (PRME) EBIT Margin (QoQ) (2024 - 2026)

Prime Medicine (PRME) EBIT Margin (QoQ) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Prime Medicine 525.98 Mn 525.98 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,705.00
Dec 31, 2025 -139,452.00
Sep 30, 2025 38,122.00
Jun 30, 2025 -118,387.00
Mar 31, 2025 -157,756.00
Dec 31, 2024 2.39 Mn